1 year return (CAGR)
35.65%
Flour Mills C. Sarantopoulos S.A. Exchange (AT, EUR)
KYSA.AT
1.56
0.00 (0.00%)
Consumer DefensivePackaged Foods
Loading...
3 year return (CAGR)
10.38%
5 year return (CAGR)
5.39%
10 year return (CAGR)
-4.14%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
6.52M
Price/Sales
0.70
Ent value
-
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.65 |
| Daily high | 1.65 |
| Daily low | 1.56 |
| Daily Volume | 0K |
| All-time high | 13492.86 |
| 1y analyst estimate | - |
| Beta | 0.08 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | 3 Jul 2002 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| KYSA.AT | S&P500 | |
| Current price drop from All-time high | -99.99% | -1.06% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 12 Sep 2016 | 9 Mar 2009 |
| Avg drop from high | -97.52% | -10.67% |
| Avg time to new high | 705 days | 12 days |
| Max time to new high | 4201 days | 1805 days |
News
INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF SEPTEMBER 30, 20261 Paris – October 8, 2026 NUMBER OF SHARES AS OF SEPTEMBER 30, 2026 Date09/30/2026Company nameKlépierre...
October 8, 2026
Argenx unexpectedly scrapped a study of its drug, Vyvgart, in patients with Sjogren's disease on Thursday. The stock plummeted in response.
October 8, 2026
Up from about US$300 million in 2025 across the US, EU4, UK and Japan, as Merck's WELIREG, the first oral targeted PCPG therapy, faces pipeline rivals from Novartis, Jazz and Perspective.Dublin, Oct. ...
October 8, 2026
VIENNA, AUSTRIA - October 7, 2026 (NEWMEDIAWIRE) - The Supervisory Board of VERBUND AG today appointed Stefan Waldner (49) as Chief Financial Officer (CFO) and a member of the Management Board. His ap...
October 7, 2026
Novartis (SWX:NOVN) just put multiple sclerosis front and center for investors, flagging 46 abstracts for MSToronto2026, including late breaking Phase III REMODEL data on remibrutinib and new Kesimpta...
October 7, 2026
Healthcare stocks rose late Wednesday afternoon, with the NYSE Healthcare Index adding 1.2% and the
October 7, 2026
Norwegian Air Shuttle’s New 737-8 Deliveries Set Up Fresh Capacity Questions CDB Aviation has delivered the first of four Boeing 737-8 jets to Norwegian Air Shuttle (OB:NAS), kicking off a new leasing...
October 7, 2026
Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index adding 1.6% and the State
October 7, 2026
In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible ur...
October 7, 2026
PARIS, October 07, 2026--Rivercell, a Paris-based biotechnology and AI company, today announced a $25 million seed round led by HV.
October 7, 2026